Effect of cell-based VEGF gene therapy on healing of a segmental bone defect

Journal of Orthopaedic Research

Volumn 27, Issue 1, 2009, Pages 8-14

  Li, Ru ^a   Stewart, Duncan J ^a   Von Schroeder, Herbert P ^a   Mackinnon, Erin S ^a   Schemitsch, Emil H ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BONE DEFECT; BONE DEVELOPMENT; BONE STRUCTURE; CELL BASED GENE THERAPY; CELL PROLIFERATION; CELL SURVIVAL; CONTROL GROUP; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FIBROBLAST; FRACTURE HEALING; GENE TRANSFER; MALE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RABBIT; STAINING; TIBIA FRACTURE;

ANIMALS; BONE AND BONES; CELL PROLIFERATION; CELL SURVIVAL; DERMIS; FIBROBLASTS; FRACTURE HEALING; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; NEOVASCULARIZATION, PATHOLOGIC; OSTEOGENESIS; RABBITS; TIBIA; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 58149271034     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20658     Document Type: Article

References (26)

1. Street J, Bao M, deGuzman L, et al. 2002. Vascular endo-thelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99:9656-9661,
2. Mayr-Wohlfart U, Waltenberger J, Hausser H, et al. 2002. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 30:472-477.
3. Nakagawa M, Kaneda T, Arakawa T, et al. 2000. Vascular endothelial growth factor (VEGF) directly enhances osteo-clastic bone resorption and survival of mature osteoclasts. FEES Lett 473:161-164.
4. Carlevaro MF, Cermelli S, Cancedda R, et al. 2000. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endo-chondral bone formation, J Cell Sci 113:59-69.
5. Pufe T, Wildemann B, Petersen W, et al. 2002. Quantitative measurement of the splice variants 120 and 164 of the angiogenic peptide vascular endothelial growth factor in the time flow of fracture healing: a study in the rat. Cell Tissue Res 309:387-392.
6. Chu TW, Wang ZG, Zhu PF, et al. 2002. Effect of vascular endothelial growth factor in fracture healing. Chung Kuo Hsiu Fu Chung Chien Wai Ko Tsa Chih [Chin J Repara Reconstr Surg] 16:75-78.
7. Campbell AIM, Kuliszewski MA, Stewart DJ. 1999. Cell-based gene transfer to the pulmonary vasculature. Am J Respir Cell Mol Biol 21:567-575.
8. Campbell AIM, Zhao Y, Sandhu R, et al. 2001. Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension. Circulation 104:2242-2248.
9. Muller R, Riiegsegger P. 1995. Three-dimensional finite element modeling of noninvasively assessed trabecular bone structures. J Med Eng Phys 17:126-133.
10. Peng H, Wright V, Usas A, et al. 2002. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110:751-759.
11. Geiger F, Bertram H, Berger I, et al. 2005. Vascular endothelial growth factor gene-activated matrix (VEGF165-GMA) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res 20:2028-2035.
12. Spector JA, Mehrara BJ, Luchs JS, et al. 2000. Expression of adenovirally delivered gene products in healing osseous tissues. Ann Plast Surg 44:522-528.
13. Evans CH, Robbins PD. 1995. Possible orthopaedic applications of gene therapy. J Bone Joint Surg 77A:1103-1114.
14. Svach DJ, Wu I, Harten RD. 2003. The effect of vascular endothelial growth factor on the healing of critical size long bone defects in rodents. 49th Annual Meeting of the Orthopaedic Research Society; p 51.
15. Baltzer AW, Lattermann C, Whalen JD, et al. 1999. A gene therapy approach to accelerating bone healing. Evaluation of gene expression in a New Zealand white rabbit model. Knee Surg Sports Traumatol Arthrosc 7:197-202.
16. Baltzer AW, Lieverman JR. 2004. Regional gene therapy to enhance bone repair. Gene Therapy 11:344-350.
17. Tarkka T, Sipola A, Jämasa T, et al. 2003. Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues. J Gene Med 5:560-566.
18. Betz OB, Betz VM, Nazarian A, et al. 2006. Direct percutaneous gene delivery to enhance healing of segmental bone defects. J Bone Joint Surg 88A:355-365.
19. Newman KB, Dunn PF, Owens JW, et al. 1995. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neo-intimal hyperplasia. J Clin Invest 96:2955-2965.
20. Schulick AH, Newman KD, Virmani R, et al. 1995. In vivo gene transfer into injured carotid arteries: optimization and evaluation of acute toxicity. Circulation 91:2407-2414.
21. Piedimonte G, Pickles RJ, Lehmann JR, et al. 1997. Replication-deficient adenoviral vector for gene transfer potentiates airway neurogenic inflammation. Am J Respir Cell Mol Biol 16:250-258.
22. Crystal RG, Mastrangeli A, Sanders A, et al. 1995. Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis. Hum Gene Ther 6:667-703.
23. Cornetta K, Morgan RA, Anderson WF. 1991. Safety issues related to retroviral-mediated gene transfer in humans. Hum Gene Ther 2:5-14.
24. Capito RM, Spector M. 2003. Scaffold-based articular cartilage repair. IEEE Eng Med Biol Mag 22:42-50.
25. Bostrom MP, Camacho NP. 1998. Potential role of bone morphogenetic proteins in fracture healing. Clin Orthop 355:244-282.
26. Friedlaender GE, Perry CR, Cole JD, et al. 2001. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg 83 (Suppl): 51-158.